96 related articles for article (PubMed ID: 15357965)
1. Structure-activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity.
Nagumo Y; Kakeya H; Yamaguchi J; Uno T; Shoji M; Hayashi Y; Osada H
Bioorg Med Chem Lett; 2004 Sep; 14(17):4425-9. PubMed ID: 15357965
[TBL] [Abstract][Full Text] [Related]
2. Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity.
Nagumo Y; Kakeya H; Shoji M; Hayashi Y; Dohmae N; Osada H
Biochem J; 2005 May; 387(Pt 3):835-40. PubMed ID: 15603555
[TBL] [Abstract][Full Text] [Related]
3. Syntheses and applications of fluorescent and biotinylated epolactaene derivatives: Epolactaene and its derivative induce disulfide formation.
Kuramochi K; Yukizawa S; Ikeda S; Sunoki T; Arai S; Matsui R; Morita A; Mizushina Y; Sakaguchi K; Sugawara F; Ikekita M; Kobayashi S
Bioorg Med Chem; 2008 May; 16(9):5039-49. PubMed ID: 18375133
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-inducing effect of epolactaene derivatives on BALL-1 cells.
Kuramochi K; Matsui R; Matsubara Y; Nakai J; Sunoki T; Arai S; Nagata S; Nagahara Y; Mizushina Y; Ikekita M; Kobayashi S
Bioorg Med Chem; 2006 Apr; 14(7):2151-61. PubMed ID: 16298530
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of epolactaene analogs as DNA polymerases inhibitors.
Kuramochi K; Mizushina Y; Nagata S; Sugawara F; Sakaguchi K; Kobayashi S
Bioorg Med Chem; 2004 May; 12(9):1983-9. PubMed ID: 15080901
[TBL] [Abstract][Full Text] [Related]
6. A novel lipid compound, epolactaene, induces apoptosis: its action is modulated by its side chain structure.
Nakai J; Kawada K; Nagata S; Kuramochi K; Uchiro H; Kobayashi S; Ikekita M
Biochim Biophys Acta; 2002 Mar; 1581(1-2):1-10. PubMed ID: 11960746
[TBL] [Abstract][Full Text] [Related]
7. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, selectively inhibits the activities of mammalian DNA polymerases and human DNA topoisomerase II.
Mizushina Y; Kobayashi S; Kuramochi K; Nagata S; Sugawara F; Sakaguchi K
Biochem Biophys Res Commun; 2000 Jul; 273(2):784-8. PubMed ID: 10873681
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of epolactaene derivatives as DNA polymerase inhibitors and anti-inflammatory compounds.
Mizushina Y; Kuramochi K; Ikawa H; Kuriyama I; Shimazaki N; Takemura M; Oshige M; Yoshida H; Koiwai O; Sugawara F; Kobayashi S; Sakaguchi K
Int J Mol Med; 2005 May; 15(5):785-93. PubMed ID: 15806299
[TBL] [Abstract][Full Text] [Related]
9. Transformation of thiols to disulfides by epolactaene and its derivatives.
Kuramochi K; Sunoki T; Tsubaki K; Mizushina Y; Sakaguchi K; Sugawara F; Ikekita M; Kobayashi S
Bioorg Med Chem; 2011 Jul; 19(14):4162-72. PubMed ID: 21708466
[TBL] [Abstract][Full Text] [Related]
10. Targeting mitochondrial transcription in fission yeast with ETB, an inhibitor of HSP60, the chaperone that binds to the mitochondrial transcription factor Mtf1.
Sun W; Wang L; Jiang H; Chen D; Murchie AI
Genes Cells; 2012 Feb; 17(2):122-31. PubMed ID: 23035257
[TBL] [Abstract][Full Text] [Related]
11. Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors.
Kakeya H; Onozawa C; Sato M; Arai K; Osada H
J Med Chem; 1997 Feb; 40(4):391-4. PubMed ID: 9046328
[No Abstract] [Full Text] [Related]
12. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, produced by a marine fungus.
Kakeya H; Takahashi I; Okada G; Isono K; Osada H
J Antibiot (Tokyo); 1995 Jul; 48(7):733-5. PubMed ID: 7649877
[No Abstract] [Full Text] [Related]
13. Identification of the heat shock protein 60 epitope involved in receptor binding on macrophages.
Habich C; Kempe K; Burkart V; Van Der Zee R; Lillicrap M; Gaston H; Kolb H
FEBS Lett; 2004 Jun; 568(1-3):65-9. PubMed ID: 15196922
[TBL] [Abstract][Full Text] [Related]
14. Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy.
Pfister G; Stroh CM; Perschinka H; Kind M; Knoflach M; Hinterdorfer P; Wick G
J Cell Sci; 2005 Apr; 118(Pt 8):1587-94. PubMed ID: 15784682
[TBL] [Abstract][Full Text] [Related]
15. Altered distribution of heat shock protein 60 (Hsp60) with dysregulated expression of DHX32.
Chen Y; Alli Z; Ackerley C; Al-Saud B; Abdelhaleem M
Exp Mol Pathol; 2007 Jun; 82(3):256-61. PubMed ID: 17174952
[TBL] [Abstract][Full Text] [Related]
16. Epo-C12 inhibits peroxiredoxin 1 peroxidase activity.
Yoda T; Furuta M; Tsutsumi T; Ikeda S; Yukizawa S; Arai S; Morita A; Yamatoya K; Nakata K; Tomoshige S; Ohgane K; Furuyama Y; Sakaguchi K; Sugawara F; Kobayashi S; Ikekita M; Kuramochi K
Bioorg Med Chem; 2021 Jul; 41():116203. PubMed ID: 34015702
[TBL] [Abstract][Full Text] [Related]
17. Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma.
Faried A; Sohda M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Eur J Cancer; 2004 Dec; 40(18):2804-11. PubMed ID: 15571964
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of phomactin derivatives as platelet activating factor antagonists.
Sugano M; Sato A; Saito K; Takaishi S; Matsushita Y; Iijima Y
J Med Chem; 1996 Dec; 39(26):5281-4. PubMed ID: 8978857
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of new 6-hydroximinosteroid analogs as cytotoxic agents.
Poza J; Rega M; Paz V; Alonso B; Rodríguez J; Salvador N; Fernández A; Jiménez C
Bioorg Med Chem; 2007 Jul; 15(14):4722-40. PubMed ID: 17531494
[TBL] [Abstract][Full Text] [Related]
20. Interaction between HSP60 and beta-catenin promotes metastasis.
Tsai YP; Yang MH; Huang CH; Chang SY; Chen PM; Liu CJ; Teng SC; Wu KJ
Carcinogenesis; 2009 Jun; 30(6):1049-57. PubMed ID: 19369584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
